Moreover, Andrés et al. demonstrated that GATA4 is a potential marker of tumor growth in PDAC and that the expression of GATA4 and GATA6 is a biomarker of poor prognosis and therapeutic response [33]. Here, GATA6 is linked to neoplasm.